Genetic suppression of β2-adrenergic receptors ameliorates tau pathology in a mouse model of tauopathies

Por Wisely, Elena V., Xiang, Yang K., Oddo, Salvatore
Publicado em 2014

Administration of a selective β2 adrenergic receptor antagonist exacerbates neuropathology and cognitive deficits in a mouse model of Alzheimer's disease

Por Branca, Caterina, Wisely, Elena V, Hartman, Lauren K, Caccamo, Antonella, Oddo, Salvatore
Publicado no Neurobiol Aging (2014)

mTOR REGULATES TAU PHOSPHORYLATION AND DEGRADATION: IMPLICATIONS FOR ALZHEIMER’S DISEASE AND OTHER TAUOPATHIES

Por Caccamo, Antonella, Magrì, Andrea, Medina, David X., Wisely, Elena V., López-Aranda, Manuel F., Silva, Alcino J., Oddo, Salvatore
Publicado em 2013

β(2) Adrenergic Receptor, Protein Kinase A (PKA) and c-Jun N-terminal Kinase (JNK) Signaling Pathways Mediate Tau Pathology in Alzheimer Disease Models

Por Wang, Dayong, Fu, Qin, Zhou, Yuan, Xu, Bing, Shi, Qian, Igwe, Benedict, Matt, Lucas, Hell, Johannes W., Wisely, Elena V., Oddo, Salvatore, Xiang, Yang K.
Publicado em 2013